Impact of fresh‐frozen plasma from male‐only donors versus mixed‐sex donors on postoperative respiratory function in surgical patients: a prospective case‐controlled study

BACKGROUND: To reduce the risk of transfusion‐related acute lung injury (TRALI), plasma products are mainly made from male donors in some countries because of the lower possibility of alloimmunization; other countries are considering this policy. The advantage of male‐only fresh‐frozen plasma (FFP) should be examined in a prospective case‐control study.

[1]  N. Soni,et al.  Ten years of hemovigilance reports of transfusion‐related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma , 2009, Transfusion.

[2]  H. Hume,et al.  TRALI: moving toward prevention , 2009, Transfusion.

[3]  S. Saidman,et al.  Testing only donors with a prior history of pregnancy or transfusion is a logical and cost‐effective transfusion‐related acute lung injury prevention strategy , 2008, Transfusion.

[4]  A. Leaver,et al.  Acute lung injury after ruptured abdominal aortic aneurysm repair: The effect of excluding donations from females from the production of fresh frozen plasma* , 2008, Critical care medicine.

[5]  M. Malinchoc,et al.  Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. , 2007, American journal of respiratory and critical care medicine.

[6]  S. Kleinman,et al.  Measures to prevent TRALI , 2007, Vox sanguinis.

[7]  K. Jakobs,et al.  Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. , 2007, Biochimica et biophysica acta.

[8]  U. Sachs,et al.  The pathogenesis of transfusion‐related acute lung injury (TRALI) , 2007, British journal of haematology.

[9]  T. Lesnick,et al.  Transfusion‐related acute lung injury and pulmonary edema in critically ill patients: a retrospective study , 2006, Transfusion.

[10]  O. Gajic,et al.  Pulmonary edema after transfusion: How to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury , 2006, Critical care medicine.

[11]  B. Phillips-Bute,et al.  Infectious complications after cardiac surgery: lack of association with fresh frozen plasma or platelet transfusions. , 2005, Journal of cardiothoracic and vascular anesthesia.

[12]  A. Artigas,et al.  Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination , 1994, Intensive Care Medicine.

[13]  Takao Shimizu,et al.  G2A Is a Proton-sensing G-protein-coupled Receptor Antagonized by Lysophosphatidylcholine* , 2004, Journal of Biological Chemistry.

[14]  N. Voelkel,et al.  Plasma and lipids from stored platelets cause acute lung injury in an animal model , 2003, Transfusion.

[15]  A. Paterson,et al.  Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium , 2003, Journal of leukocyte biology.

[16]  P. Holland,et al.  TRALI: correlation of antigen‐antibody and monocyte activation in donor‐recipient pairs , 2003, Transfusion.

[17]  Y. Soda,et al.  An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. , 2002, Clinical biochemistry.

[18]  J. Ernerudh,et al.  A randomized controlled trial oftransfusion‐related acute lung injury: is plasma from multiparous blood donors dangerous? , 2001, Transfusion.

[19]  G R Bernard,et al.  The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. , 1998, American journal of respiratory and critical care medicine.

[20]  A. Paterson,et al.  The association of biologically active lipids with the development of transfusion‐related acute lung injury: a retrospective study , 1997, Transfusion.

[21]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[22]  G. Feuerstein,et al.  Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[23]  S. Moore,et al.  Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. , 2015, The American review of respiratory disease.